PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
Medscape27d
Screening and Management of Metabolic Dysfunction–Associated Fatty Liver Disease in Endocrine Practice
The point is that a FIB-4 score ... liver histology, and insulin sensitivity. Weight loss has a dose-dependent effect. So, losing 5% of weight can lead to a reduction in liver steatosis.
Business Insider3d
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology ... serve as an aid to trial pathologists in scoring liver biopsies at enrollment and follow-up visits.
The Manila Times6d
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...
Devdiscourse8d
AI transforms liver transplants: A game-changer for organ matching and surgery
AI-powered models can analyze large datasets in real-time, optimizing organ distribution across wider geographic regions.
Morningstar6d
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
SINGAPORE, March 17, 2025 /PRNewswire/ -- HistoIndex, a global leader in stain-free digital pathology ... associated steatotic liver disease (MASLD) characterized by steatosis and inflammation ...